Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about MDMA/assisted therapy Recent news which mentions MDMA/assisted therapy Two Top Biotechs Forge MDMA Supply Deals For Clinical Research March 26, 2024 Tickers MDXXF NEWS NUMIF OPTHF Tags Biotech MDXXF OPTHF From Benzinga Atai Life Sciences Shows Positive Results In Phase 1 Clinical Study For PTSD Treatment January 04, 2024 Tickers ATAI NEWS Tags Biotech R/MDMA Psychedelics From Benzinga Could MDMA Revolutionize PTSD Treatment? In Historic Move, FDA Considers New Drug Application December 12, 2023 Tags Psychedelics Market News Cannabis From Benzinga Canadian Practitioners Can Now Enroll In MDMA-Assisted Psychotherapy Training Program September 25, 2023 Tags Benzinga MDMA/assisted therapy TheraPsil From Benzinga Psychedelics Researchers & Industry Leaders Weigh In On Groundbreaking PTSD Treatment News September 15, 2023 Tickers NUMIF Tags NUMIF PTSD treatment Benzinga From Benzinga Treating PTSD With MDMA Therapy: New Results From MAPS Clinical Study, FDA Submission Next September 14, 2023 Tags Market News Markets Cannabis From Benzinga Fluence Inks Deal To Bring Brazil's Psychedelic Therapy Training Scene To New Heights July 26, 2023 Tags News Management Legal From Benzinga MDMA Deals: Optimi Supplies Numinus-MAPS Program & PharmAla Exports To Australian University June 20, 2023 Tickers NUMIF OPTHF PMBHF Tags MDMA/assisted therapy Benzinga NUMIF From Benzinga Numinus Partners With MAPS To Conduct Phase 1 MDMA Assisted Therapy Investigational Study June 16, 2023 Tickers MAPS NUMIF Tags Market News Cannabis Penny Stocks From Benzinga Promising Milestone: FDA Approves California-Based Trial Assessing MDMA For Schizophrenia June 12, 2023 Tickers PMBHF Tags Guidance Schizophrenia Markets From Benzinga Creso Pharma's LOI For Import Of Swiss MDMA And Psilocybin Therapeutics To Australia June 09, 2023 Tickers COPHF MNMD Tags COPHF Psychedelics Australia Psychedelics From Benzinga EXCLUSIVE: MDMA Therapy Experts Debate Upcoming Approval And Psychedelic Market Opps April 19, 2023 Tickers AWKNF Tags Legal Courtney Barnes George McBride From Benzinga Two Psychedelics Companies Collaborate To Provide Clinical-Grade MDMA Capsules For Authorized Patients And Studies April 11, 2023 Tickers FLHLF Tags Markets FLHLF News From Benzinga MDMA Transdermal Patch Moves Toward First-In-Human Trials: Latest Development Update April 03, 2023 Tickers PHRRF RVVTF Tags PHRRF Market News Cannabis From Benzinga MDMA News: Exclusive Supply Deal With Awakn Life Sciences & Canadian Company Expands Psychedelics Production March 02, 2023 Tickers AWKNF Tags Supply Chain Psychedelics Controlled Substances Act From Benzinga Australia's Psychedelics Therapy Provides Hope For Treatment-Resistant Mental Health Conditions February 07, 2023 Tickers NUMIF Tags News Legal Psilocybin/Assisted Therapy From Benzinga Psyched: Australia Legalizes Psychedelics Therapy, BC's Decrim, State Bills, Millions For Trials & Clinics February 06, 2023 Tickers IWINF ORIG PHRRF PSIL Tags Markets Canada Psychedelics News From Benzinga MDMA News: Optimi's New Drug Now Available, Revive Advances Transdermal Patch Evaluations February 06, 2023 Tickers OPTHF PHRRF RVVTF Tags Health Canada Special Access Program Markets RVVTF From Benzinga MDMA Therapy For Chronic PTSD: Neuroimaging With Veterans & First Responders Provides Further Evidence January 23, 2023 Tags Benzinga Veterans MDMA/assisted therapy From Benzinga Psyched: NY Discusses Regulations, MDMA For PTSD Aims For Legalization, Shrooms For Eating Disorders & More January 10, 2023 Tickers PSIL PSYK TRYPF Tags Global TRYPF Benzinga From Benzinga Is Psychedelic Treatment Around The Corner? MDMA For PTSD Checks Positive In MAPS' 2nd Phase 3 Trial January 05, 2023 Tags PTSD Markets Guidance From Benzinga Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More November 21, 2022 Tickers AGNPF BMNDF CMND CMPS Tags AGNPF BMNDF REUN From Benzinga MAPS Completes Second Phase 3 Trial Of MDMA-Assisted Therapy For PTSD, Topline Data & New Drug Application Next November 17, 2022 Tags Markets MAPS PBC News From Benzinga Atai's New MDMA-Based EMP-01 Compound Moves Forward To The Clinical Stage September 27, 2022 Tickers ATAI Tags Glenn Short Markets ATAI From Benzinga Awakn Shares Its Q2 2022 Results, Showing Consistent Growth On Its Second Full Financial Year September 17, 2022 Tickers AWKNF Tags Psychedelics AWKNF Behavioral Addictions From Benzinga Canadian Psychedelics Company Reduces Manufacturing Time Of MDMA By Two Thirds September 07, 2022 Tags Market News Robert August Cannabis From Benzinga Canada: MDMA-Assisted Therapy Trials Reviewed By Health Canada, Here's What's Happening July 25, 2022 Tickers MAPS Tags News The Remedy Institute Legal From Benzinga Missouri Patients With Life-Threatening Illnesses Can Seek Psychedelic Treatments Under 'Right To Try' Law January 13, 2022 Tags LSD Markets Politics From Benzinga Australian Psychiatrist Sues State Of Victoria For Denying MDMA Treatment For Ailing Patient November 17, 2021 Tags MDMA/assisted therapy Benzinga FDA From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.